Search

everythinglearnresearchcommunity

for

Search:↓

Simvastatin/ezetimibe may help some patients with severe alopecia areata regrow hair.

Alopecia areata patients have lower vitamin D levels than healthy individuals.

Some treatments for autoimmune hair loss work, but JAK inhibitors like tofacitinib are promising for regrowth.

Activated and non-activated PRP are equally safe and effective for treating alopecia areata.

Females have a higher lifetime risk of alopecia areata than males.

Thymoma with alopecia areata may be linked to abnormal immune cells.

The gel improves hair regrowth and reduces irritation in alopecia areata treatment.

Trichoscopy helps diagnose and track alopecia areata by examining specific hair and scalp markers.

Most women aged 20-40 in the study lost hair diffusely and in volume over 6 weeks to 6 months, mainly due to telogen effluvium, often without a clear cause.

Some dermatologists in Saudi Arabia prescribe Tofacitinib for hair loss, but many don't due to its unavailability and safety concerns.

Alopecia areata needs more recognition and better treatment access in Latin America to improve patient care and outcomes.

Alopecia Areata is treated with drugs and therapies to reduce inflammation and immune response.

Janus kinase inhibitors show promise in treating alopecia areata but need better topical formulations.

Alopecia areata is caused by immune attacks on hair follicles, affecting hair growth and quality of life.

Two people had unusual ring-shaped hair loss due to an autoimmune disorder.

Alopecia Areata affects 2% globally, with treatments like essential oils, garlic, and JAK inhibitors showing promise, but more research is needed.

Alopecia areata can cause unpredictable hair loss, and treatments like corticosteroids and minoxidil may help but have varying side effects.

Patients with alopecia areata in Saudi Arabia understand the condition's seriousness but still face significant psychological challenges.

Higher IgE levels may play a role in alopecia areata, especially in males, children, and severe cases.

Non-scarring alopecia in females affects emotional well-being and requires accurate diagnosis and personalized treatment.

Using growth factors and microneedling shows promise for hair regrowth in Alopecia Areata, but more research is needed.

Alopecia areata patients, especially women with nail issues or atopic diseases, are at higher risk for other autoimmune diseases.

Baricitinib helped some patients with tough-to-treat hair loss regrow hair, but more research is needed on its safety.

The paper concludes that the new medication baricitinib needs further testing in a more diverse group of patients with alopecia areata.

Higher CD70 and CD27 gene expression in alopecia areata lesions predicts disease severity and activity.

Pediatric alopecia areata needs better treatments and psychological support.

Alopecia areata patients don't have increased atherosclerosis risk, but may have higher cardiovascular risk due to smoking, blood sugar, and blood pressure.

Vitamin D deficiency is common in people with certain types of hair loss, like alopecia areata and female pattern hair loss.

Treg cell-based therapies might help treat hair loss from alopecia areata, but more research is needed to confirm safety and effectiveness.

Some breast cancer patients developed permanent hair loss after chemotherapy and hormonal therapy, showing patterns similar to common baldness and alopecia areata.